Invesco’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-68,159
| Closed | -$1.47M | – | 3744 |
|
|
2025
Q4 | $1.47M | Sell |
68,159
-474,454
| -87% | -$9.21M | ﹤0.01% | 2749 |
|
|
2025
Q3 | $8.29M | Sell |
542,613
-206,262
| -28% | -$2.68M | ﹤0.01% | 1941 |
|
|
2025
Q2 | $6.63M | Buy |
748,875
+699,201
| +1,408% | +$6.14M | ﹤0.01% | 2033 |
|
|
2025
Q1 | $389K | Sell |
49,674
-2,468
| -5% | -$20.7K | ﹤0.01% | 3253 |
|
|
2024
Q4 | $548K | Buy |
52,142
+1,177
| +2% | +$14.3K | ﹤0.01% | 3198 |
|
|
2024
Q3 | $668K | Buy |
50,965
+3,014
| +6% | +$45.9K | ﹤0.01% | 3101 |
|
|
2024
Q2 | $674K | Buy |
+47,951
| New | +$782K | ﹤0.01% | 3151 |
|
|
2020
Q4 | – | Sell |
-385,892
| Closed | -$1.95M | – | 3770 |
|
|
2020
Q3 | $1.95M | Sell |
385,892
-349,229
| -48% | -$2.54M | ﹤0.01% | 2509 |
|
|
2020
Q2 | $5.94M | Buy |
735,121
+2,109
| +0.3% | +$18.6K | ﹤0.01% | 1899 |
|
|
2020
Q1 | $5.82M | Buy |
+733,012
| New | +$5.63M | ﹤0.01% | 1794 |
|
|
2016
Q2 | – | Sell |
-398,870
| Closed | -$4.4M | – | 3684 |
|
|
2016
Q1 | $4.4M | Sell |
398,870
-45,854
| -10% | -$455K | ﹤0.01% | 1962 |
|
|
2015
Q4 | $5.43M | Buy |
444,724
+86,049
| +24% | +$1.34M | ﹤0.01% | 1850 |
|
|
2015
Q3 | $5.85M | Sell |
358,675
-152,834
| -30% | -$3.37M | ﹤0.01% | 1774 |
|
|
2015
Q2 | $10.8M | Buy |
511,509
+142,785
| +39% | +$2.56M | ﹤0.01% | 1518 |
|
|
2015
Q1 | $6.63M | Buy |
368,724
+160,096
| +77% | +$2.51M | ﹤0.01% | 1781 |
|
|
2014
Q4 | $3.57M | Buy |
208,628
+207,915
| +29,161% | +$2.97M | ﹤0.01% | 2136 |
|
|
2014
Q3 | $10K | Buy |
713
+72
| +11% | +$1.03K | ﹤0.01% | 4033 |
|
|
2014
Q2 | $10K | Buy |
+641
| New | +$7.73K | ﹤0.01% | 4013 |
|
|
2014
Q1 | – | Sell |
-78,346
| Closed | -$631K | – | 4093 |
|
|
2013
Q4 | $631K | Sell |
78,346
-4,929
| -6% | -$34.8K | ﹤0.01% | 3354 |
|
|
2013
Q3 | $546K | Sell |
83,275
-63,793
| -43% | -$392K | ﹤0.01% | 3361 |
|
|
2013
Q2 | $903K | Buy |
+147,068
| New | +$760K | ﹤0.01% | 2935 |
|
Other funds holding AVDL
Invesco's AVDL Position: Q1 2026 in Review
Invesco sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 68,159 shares — an estimated $1.47M sold.
Invesco first reported a position in AVDL in Q2 2013 and held it in 21 quarters. The position peaked at $10.8M in Q2 2015. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.
- Invesco reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Invesco sold 68,159 Avadel Pharmaceuticals shares in Q1 2026, an estimated $1.47M.
- Invesco first reported a position in Avadel Pharmaceuticals in Q2 2013 and held it in 21 quarters.
- Invesco's Avadel Pharmaceuticals position peaked at $10.8M in Q2 2015.
- 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.